Starting dose and dose adjustment of non-vitamin K antagonist oral anticoagulation agents in a nationwide cohort of patients with atrial fibrillation

This study aims to provide real-world data about starting-dose of NOACs and dose-adjustment in patients with atrial fibrillation (AF). In fact, even if new oral anticoagulation agents (NOACs) have a predictable effect without need for regular monitoring, dose-adjustments should be performed accordin...

Descripción completa

Detalles Bibliográficos
Autores principales: Gozzo, L., Di Lenarda, A., Mammarella, F., Olimpieri, P. P., Cirilli, A., Cuomo, M., Gulizia, M. M., Colivicchi, F., Murri, G., Kunutsor, S. K., Gabrielli, D., Trotta, F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8526656/
https://www.ncbi.nlm.nih.gov/pubmed/34667256
http://dx.doi.org/10.1038/s41598-021-99818-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8526656/
https://www.ncbi.nlm.nih.gov/pubmed/34667256
http://dx.doi.org/10.1038/s41598-021-99818-4

Ejemplares similares